Icon

VASCEPA (nda202057)- (1GM,500MG)

ICOSAPENT ETHYL AMARIN PHARMS
1GM,500MG
Yes Yes
2033-Jun-28 2017-Jul-26
None 2015-Jul-26
None No
VASCEPA is an ethyl ester of eicosapentaenoic acid (EPA) indicated: • as an adjunct to maximally tolerated statin therapy to reduce the risk of myocardial infarction, stroke, coronary revascularization, and unstable angina requiring hospitalization in adult patients with elevated triglyceride (TG) levels (≥ 150 mg/dL) and o established cardiovascular disease or o diabetes mellitus and 2 or more additional risk factors for cardiovascular disease. • as an adjunct to diet to reduce TG levels in adult patients with severe (≥ 500 mg/dL) hypertriglyceridemia.
8 0 8
Total Other Developers 12
Drugs with Suitability No
1GM ** ** Down - 8
500MG ** ** Up - 6
NDA Sales Available Total Generic Sales Available
Yes 7
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ****** ******** ******* ******* *********** *** ****** **, *********, ******* *** ***, ****** (***) ***
****** ***** ****-**** ******** ***. *********** **** ****** ****, ********, **** (**) *****, ****** ****** (***) ***
****** ***** ************ ****** ************ *.*.*. *********** *** ******* ***** ***** *, *************, ******** *****, ***** (***) ***
****** ******* ****** ******* ****** ******* ******* *********** ** **/*,******************, ********* *****, ****** *****, *********, ********* ******, ***** (***) ***
****** ********* ******* ********* ******* *************** (*****) **., *** *********** **.**, *** ******* ****, **** **** *** ********** *********** ********, *****, ***** ******, ***** (***) ***
****** ****** ****** *** ****** *************** *** *********** *** * ********** **, ******* *****, *** **** (**) *****, ****** ****** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.